Mushrooms are increasingly being recognized as an important food for their significant role in human health, nutrition and disease. Mushrooms provide a wide variety of physiologically active components: *Pleurotus sajorcaju* inhibits hypertensive effects through its active ingredients, which affect the renin-angiotensin system ([@B3]), *Tricholoma magnivelare* produces vasorelaxation because of its lectin content ([@B27]), *P. ostreatus* possesses antitumor activity ([@B29]) and hypoglycaemic effects on experimentally induced diabetic rat ([@B4]), *Lentinus edode*s and *Grifola frondosa* have antihypertensive effects in spontaneously hypertensive rats ([@B19]) and *Agaricus bisporus* decreases low-density lipoprotein-cholesterol (LDL-C) in serum by increasing the expression of LDL receptor at mRNA level and LDL receptor activity ([@B9]).

Experimental evidence suggests that one of the most important food components that help to reduce serum cholesterol is its polyunsaturated fatty acid (PUFA) content ([@B14], [@B16]; [@B10], [@B11]; [@B17]). Arachidonic acid exacerbates platelet functions ([@B18]), whereas linolenic acid (LNA) acts as a precursor of the physiologically important PUFA, such as eicosapentaenoic acid (EPA; C~20:5~, ω-3) and docosahexaenoic acid (DHA; C~22:6~, ω3) ([@B23]). There is considerable data supporting the hypothesis that the health benefit obtained through the lowering of blood cholesterol may be derived from the effects of EPA and DHA ([@B13]). In addition to their roles in the development and function of the central nervous system, these two fatty acids play an important role in the physiological functions of the cardiovascular system ([@B18]). Thus, one of the objectives of the present study was to generate awareness of the beneficial effects of edible mushrooms, particularly of oyster mushrooms, on hypercholesterolaemia, which poses serious health problems in both developed and developing countries.

Materials and Methods
=====================

Animals
-------

Forty young Long Evans rats (*Rattus rattus*) of 114 ± 12 g (mean ± SD) were used in the present study. Rats were housed in an animal room at 23 ± 2℃, under 12 h dark-light cycles and then divided randomly into five groups. Rats were fed a basal diet supplemented with, no cholesterol or mushroom (normocholesterolemic control rats; NC), 1% cholesterol (hypercholesterolemic rats; HC), 1% cholesterol and 5% powder of *Pleurotus ostreatus* (HC + PO group rats), 1% cholesterol and 5% powder of *Pleurotus sajor-caju* (HC + PS group rats), 1% cholesterol and 5% powder of *Pleurotus florida* (HC + PF group rats).

Diet composition and feeding
----------------------------

The composition of the basal diet was as follows (g/100 g). Wheat flower 50, rice powder 11, wheat bran 19, casein (non fat) 8, egg white 10, soybean oil 1, table salt 0.5, vitamin mixture 0.25 and mineral mixture 0.25. The composition of the vitamin mixture in the diet was as follows (gram/100g vitamin mixture): retinyl acetate 9.5 × 10^-4^, cholecalciferol 1.2 × 10^-3^, α-tochoferol acetate 0.05, thiamin hydrochloride 2.4, nicotinic acid 12, riboflavin 2.4, D-calcium pantothenate 9.6, pyridoxine hydrochloride 1.2, folic acid 9.5 × 10^-2^, vitamin K 0.25, cyanocobalamine 9.5 × 10^-3^, inositol 47.95 and ascorbic acid 24.0. The composition of the mineral mixture added to diet was as follows (g/100 g of mineral): calcium gluconate 28.5, K~2~HPO~4~ 17.3, CaCO~3~ 26, MgSO~4~ 12.6, KCl 12.6, CuSO~4~ 0.06, FeSO~4~ 0.3, MnSO~4~ 0.55, NaF 2.5 × 10^-4^, KI 9 × 10^-4^, sodium molybdate 3 × 10^-4^, SeO~2~ 3 × 10^-4^ and CrSO~2~ 1.5 × 10^-3^. Rats were feed for 40 days.

Collection of oyster mushrooms
------------------------------

Mature fruiting bodies of *Pleurotus ostreatus*, *P. sajor-caju*, and*P. florida* were collected from the National Mushroom Development and Extension Centre, Savar, Dhaka, Bangladesh. The fruiting bodies were dried in sunlight and crushed into powder. The powder was mixed with the basal diet.

Plasma TG estimation
--------------------

Plasma triglyceride (TG) was measured enzymatically using the glycerophosphate oxidase assay ([@B2]). In this method, lipase catalyzed the hydrolysis of triglycerides to yield glycerol and free fatty acids. Glycerol concentration was then determined with the Trinder reaction using glycerol kinase, glycerol-3 phosphate oxidase and peroxidase. The end product was the quinoneimine dye (red). Its absorbance was measured spectrophotometrically at 546 nm which was directly proportional to triglyceride concentration.

Plasma TC estimation
--------------------

Plasma total cholesterol (TC) was measured enzymatically using the cholesterol oxidase assay ([@B2]). In this method, cholesterol esterase (ChE) first catalyzed the hydrolysis of cholesterol which was oxidized by cholesterol oxidase (ChO) to yield hydrogen peroxide. In a coupled reaction catalyzed by peroxidase (POD), quinoneimine dye (red) was formed from hydrogen peroxide, 4-aminoantipyrine and phenol. The absorbance of the dye was measured spectrophotometrically at 546 nm which was directly proportional to cholesterol concentration.

Estimation of plasma lipoproteins
---------------------------------

High-density lipoprotein cholesterol (HDL-C) was measured by the same procedure of cholesterol estimation after precipiting low-density lipoprotein cholesterol (LDL-C) and very low density lipoprotein cholesterol (VLDL-C) using magnesium sulfate and phosphotungstic acid.

Low-density lipoprotein cholesterol was calculated as follows ([@B2]):

LDL-C = \[TC - (HDL-C + TG/5)\]

And very low density lipoprotein cholesterol was calculated as:

VLDL-C = \[TC - (HDL-C + LDL-C)\]

Estimation of plasma total bilirubin
------------------------------------

Plasma total bilirubin was measured with a colourimetric test- Jendrassic- Grof method. Bilirubin first reacted with diazotized sulphuric acid (DSA) and in the presence of an accelerator (caffeine) forms a red azo dye. The absorbance was measured spectrophotometrically at 546 nm which was directly proportional to bilirubin concentration.

Estimation of plasma creatinine
-------------------------------

Plasma creatinine was measured using the Jaffe reaction ([@B2]). In the Jaffe reaction, creatinine reacts with alkaline picrate to produce a reddish-orange colored complex. The absorbance was measured spectrophotometrically at 520 nm which was directly proportional to the creatinine concentration.

Estimation of plasma urea
-------------------------

Plasma urea was measured using the Barthelot method ([@B2]). In this method, after urea was hydrolyzed with urease, the ammonium ion formed was reacted with phenol and hypochlorite in alkaline medium to form indophenol. Nitropruside was used to catalyze the reaction. The absorbance of the dissociated indophenol, a blue chromogen, was measured spectrophotometrically at 560 nm which was directly proportional to the concentration of ammonia formed from urea.

Estimation of plasma uric acid
------------------------------

Plasma uric acid was measured using uricase method ([@B2]). Uricase catalyzed the oxidation of uric acid to allantoin and H~2~O~2~. In the presence of peroxidase, H~2~O~2~ reacted with 4-aminoantipyrine and 3,5-dichloro-2-hydroxybenzenesulphonate to form a quinoneimine dye. The absorbance was measured spectrophotometrically at 520 nm, which was directly proportional to the uric acid concentration.

Analysis of plasma enzyme profile
---------------------------------

The activity of the plasma transaminases, glutamate pyruvate transaminase (GPT) and glutamate oxaloacetate transaminase (GOT) were determined using the kinetic method ([@B2]). The oxoacids formed in the transaminase reaction were measured indirectly by enzymatic reduction to the corresponding hydroxyacids. The accompanying change in NADH concentration was monitored spectrophotometrically at 340 nm. Plasma alkaline phosphatase (ALP) activity was determined using 4-nitrophenyl phosphate. ALP catalyzed the hydrolysis of 4-nitrophenyl phosphate, forming phosphate and free 4-nitrophenol, which in dilute acid solutions was colorless but under alkaline condition 4-nitrophenol was converted to the 4-nitrophenoxide ion, which is an intense yellow color. The absorbance of this color compound was measured spectrophotometrically at 420 nm for the determination of plasma alkaline phosphatase activity.

Analysis of fecal cholesterol and total lipid
---------------------------------------------

Feces of rats were collected every day and dried. Total lipid was extracted by using chloroform: methanol ([@B7]). One gram of dried (powdered) feces was mixed with 10 *ml* of chloroform: methanol (2 : 1) solution and allowed to stand for 3 days with regular mixing. Then, the solution was filtered and the methanol was aspirated and the chloroform evaporated. The extracted lipid was then weighed. 2 *ml* of H~2~O was then added and made suspension by using bath sonicator. This suspension was then used to estimate cholesterol content in feces. Cholesterol was estimated by enzymatic method using the cholesterol oxidase assay.

Statistical analysis
--------------------

Results were expressed as mean ± SEM. All parameters for inter group differences were analyzed by one-way ANOVA followed by post hoc operations. The statistical program used was SPSS 11.5. (*P* \< 0.05 was considered statistically significant).

Results and Discussion
======================

Mushroom feeding reduced body weight in hypercholesterolemic rats. Feeding of *P. sajor-caju*, *P. ostreatus* and *P. florida* reduced body weight significantly in hypercholesterolemic rats by 17.36%, 23.37% and 24.13%, respectively ([Table 1](#T1){ref-type="table"}). This finding is of special significance because obesity is associated with numerous diseases including diabetes, atherosclerosis, coronary heart disease and others ([@B24]).

Plasma TC, TG, HDL-C, LDL-C, VLDL-C in NC, HC, HC + PS, HC + PO, HC + PF rats after mushroom feeding for 40 days are presented in [Table 2](#T2){ref-type="table"} and bilirubin, creatinin and blood urea nitrogen (BUN) levels are presented in [Table 3](#T3){ref-type="table"}. [Table 4](#T4){ref-type="table"} shows the plasma enzyme profiles. In HC rats, plasma TC increased by 21% compared to levels in NC rats. Plasma TC concentrations decreased by 21% in HC + PS rats, by 37% in HC + PO rats and by 16% in HC + PF rats compared to HC rats. In HC rats, plasma TG increased by 55% compared to levels in NC rats. Plasma TG concentrations decreased by 24% in HC + PS rats, by 45% in HC + PO and by 14% in HC+PF rats compared to HC rats. In HC rats, plasma HDL-C levels decreased by 35% and plasma LDL-C level increased by 144% compared to levels in NC rats. Plasma HDL-C level increased slightly, but not significantly in HC + PS and HC + PF rats compared to HC rats. But HC + PS, HC + PO and HC + PF rats showed significant decreases in plasma LDL-C levels by 59%, 47% and 41%, respectively compared to HC rats. The ratio of plasma LDL-C to HDL-C is shown in [Fig. 1](#F1){ref-type="fig"}. In HC rats, this ratio increased by 266%, compared to NC rats. But mushroom feeding reduced the ratio significantly in HC + PS, HC + PO and HC + PF rats by 64%, 45% and 41% respectively compared to HC rats. There was no significant difference in plasma bilirubin, creatinin and BUN levels in the hypercholesterolemic and mushroom-fed hypercholesterolemic rats. Also, the enzyme profiles of different rat groups are not significantly different, although all three types of mushroom feeding have slightly reduced the GOT, GPT and ALP activity in plasma.

The present study provides evidence that feeding 5% oyster mushrooms to rats significantly ameliorates the plasma atherogenic lipid profiles in experimentally induced hypercholesterolemic rats. Rats are particularly resistant to the development of hypercholesterolaemia and atherosclerosis ([@B28]; [@B6]) and have a strong capability to maintain their plasma cholesterol ([@B8]; [@B25]; [@B22]). Therefore, in order to induce hypercholesterolaemia or atherosclerosis in rats, cholesterol feeding is associated with other additives, including bile acids and propylthiouracil (an anti-thyroid drug), which increase the intestinal absorption of cholesterol ([@B5]; [@B21]). However, in the present study, the addition of 1% cholesterol to the basal diet without bile acids and/or anti-thyroid drugs produced hypercholesterolaemia in the rats, because cholesterol feeding itself increases bile acid secretion by approximately three to four folds in rats ([@B26]). The 21% increase in plasma cholesterol in the hypercholesterolemic rats in the present study was comparable to that reported by Bobek et al. ([@B1]), who fed rats cholesterol (0.3%) diet with added bile acids (0.5%) and showed a 1.7 fold higher cholesterolaemia in their cholesterol fed rats compared with normal rats.

In this experiment, 5% mushroom feeding on rats significantly repressed the increment of plasma cholesterol. The mechanism by which mushrooms reduce plasma TC levels in hypercholesterolemic rats is not clearly understood. Mushrooms contain the hypocholesterolaemic agent mevnolin (monacolin K, lovastatin) ([@B12]), which may be involved in decreasing the activity of the 3-hydroxy-3-methylglutaryl coenzyme A (HMGCoA) reductase enzyme ([@B1]), the rate-limiting enzyme for cholesterol biosynthesis. Thus, mushroom feeding may involve the suppression of endogenous cholesterol biosynthesis by inhibiting the activity of HMG-CoA reductase activity. In addition, mushroom contains water soluble gel forming substances including β-1, 3-D-glucan and pectin, which bind to bile acids, thereby inhibiting cholesterol-bile micelle formation and cholesterol resorption

The low level of LDL-C in control rats suggests that the principal cholesterol carrying lipoprotein in normocholesterolemic rodents, including rats are not the LDL particles; rather they are HDL and VLDL. However, when rats become hypercholesterolemic, the LDL-C level increased 2\~3 fold over normocholesterolemic rats, again demonstrating that the principal cholesterol carrying lipoprotein in hypercholesterolemic rats was LDL and the carriers were probably HDL and VLDL. Our results of reduced LDL-C after mushroom feeding are consistent with a similar report suggesting decrease of LDL from rat blood ([@B4]). Usually, a high level of LDL-C and a low level of HDL-C indicate an imbalance between cholesterol transport from the liver to extrahepatic tissues and back to the liver. Mushroom feeding significantly decreased LDL/HDL ratio in hypercholesterolemic rats. Thus, mushrooms may provide an important health benefit by increasing plasma HDL-C and decreasing plasma LDL-C. The process of excreting cholesterol from the body begins with the hydrolysis of LDL-C and HDL-C ester into free cholesterol in the liver. The free cholesterol is then either, secreted immediately or converted into bile acids in the bile ducts and then secreted. The fruiting bodies of mushrooms increase fecal cholesterol ([Table 5](#T5){ref-type="table"}). Thus, the decreased plasma cholesterol may also be attributed to such a mechanism. The higher level of plasma HDL-C indicates that more cholesterol from peripheral tissues was returning to the liver for catabolism and subsequent excretion. Plasma VLDL-C and TG content in mushroom fed hypercholesterolemic rats were lower compared to the hypercholesterolemic control rats. VLDL-C is the major transport vehicle for the TG from the liver to extrahepatic tissues, whereas LDL-C is not secreted as such the liver; rather, it seems to be formed from VLDL-C after partial removal of TG by lipoprotein lipase ([@B20]). After feeding cholesterol to rats, LDL-C became the prime carrier for cholesterol, then consequently leading to a decreased cholesterol content of VLDL-C and HDL-C in mushroom fed hypercholesterolemic rats.

The present results suggest that oyster mushroom ingestion has significant health benefits through the modulation of physiological functions that include various atherogenic lipid profiles in hypercholesterolaemia. Therefore, oyster mushroom may be a good source of nutrition that may also act as a prophylactic against hypercholesterolaemia, hyperlipidaemia and related complications, which are the risk factors of atherosclerosis.
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###### 

Effects of *P. sajor-caju*, *P. ostreatus* and *P. florida* feeding on the body weight of hypercholesterolemic rats
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The results are the mean ± SEM. Data was analyzed by one way ANOVA and then post hoc LSD test. ^\*^Indicates significant difference at P0.05 level. NC, normo-cholesterolemic rats; HC, hypercholesterolemic rats; HC + PS, *P. sajor-caju* fed hypercholesterolemic rats; HC + PO, *P. ostreatus* fed hypercholesterolemic rats; HC + PF, *P. florida* fed hypercholesterolemic rats.
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Effects of *P. sajor-caju*, *P. ostreatus* and *P. florida* mushrooms on plasma lipid profiles of hypercholesterolemic rats
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The results are the mean±SEM. Values in the same row that do not share a common superscript are significantly different at *P* \< 0.05 (one way ANOVA then LSD post hoc comparison). TC, total cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; VLDL-C, very low-density lipoprotein cholesterol.
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Effects of *P. sajor-caju*, *P. ostreatus* and *P. florida* mushrooms on liver and kidney function parameters of hypercholesterolemic rats

![](mb-37-37-i003)

The results are the mean ± SEM. Values in the same row that do not share a common superscript are significantly different at *P* \< 0.05 (one way ANOVA then LSD post hoc comparison); BUN, blood urea nitrogen.
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Effects of *P. sajor-caju*, *P. ostreatus* and *P. florida* mushrooms on plasma enzyme profile related to liver and kidney function of hypercholesterolemic rats
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The results are the mean ± SEM. Values in the same row that do not share a common superscript are significantly different at *P* \< 0.05 (one way ANOVA then LSD post hoc comparison). GOT, glutamate oxaloacetate transaminase; GPT, glutamate pyruvate transaminase; ALP, alkaline phosphatase.
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Effects of *P. sajor-caju*, *P. ostreatus* and *P. florida* on fecal total lipid and cholesterol
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The results are the mean ± SEM. Values in the same row that do not share a common superscript are significantly different at *P* \< 0.05 (one way ANOVA then LSD post hoc comparison).
